Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Non-cash Items (2020 - 2025)

Historic Non-cash Items for Maxcyte (MXCT) over the last 6 years, with Q3 2025 value amounting to $14.4 million.

  • Maxcyte's Non-cash Items fell 3056.67% to $14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.4 million, marking a year-over-year decrease of 3056.67%. This contributed to the annual value of $10.1 million for FY2024, which is 3644.27% down from last year.
  • Maxcyte's Non-cash Items amounted to $14.4 million in Q3 2025, which was down 3056.67% from $19.5 million recorded in Q2 2025.
  • In the past 5 years, Maxcyte's Non-cash Items registered a high of $66.5 million during Q4 2021, and its lowest value of $23825.0 during Q4 2022.
  • Over the past 5 years, Maxcyte's median Non-cash Items value was $24.5 million (recorded in 2024), while the average stood at $25.6 million.
  • As far as peak fluctuations go, Maxcyte's Non-cash Items plummeted by 9996.42% in 2022, and later soared by 6644354.67% in 2023.
  • Quarter analysis of 5 years shows Maxcyte's Non-cash Items stood at $66.5 million in 2021, then plummeted by 99.96% to $23825.0 in 2022, then soared by 66443.55% to $15.9 million in 2023, then crashed by 36.44% to $10.1 million in 2024, then soared by 42.63% to $14.4 million in 2025.
  • Its Non-cash Items stands at $14.4 million for Q3 2025, versus $19.5 million for Q2 2025 and $22.2 million for Q1 2025.